ZenithBIO Successes Highlight Flexibility, Network & Breadth of Industry Experience For a Specialty Pharma Client: Against the odds: Identified a viable P-3 clinical asset. For a private biotech Client: Conducted in-depth KOL & clinician interviews that identified critical commercial end points for their clinical development program. For a Drug Delivery Client: Pipeline analyses combining KOL interviews with market data increased valuation during M&A negotiations. For Virtual Companies: Seamless interaction with other external consulting groups across the biopharma functional & commercial areas.	Therapeutic Areas: Broad Experience Across Specialty & Primary Care Conditions
	AutoImmune & Inflammatory Diseases Anti-Infectives Cardiology: Acute & Chronic CNS Diabetes Endocrine GI Oncology Respiratory Diseases Transplantation Urology Uveitis Pain Women’s health
Success stories after-the-fact look easy, but the challenge is understanding the strategic potential of opportunities as well as the risks early on, in order to optimize the value of deals, pipelines, and product launches.